QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPSChina Warehouse
What is Arimidex?
Anastrozole (Arimidex) is a third-generation non-steroidal triazole aromatase inhibitor — reversible competitive CYP19A1 inhibition (~97% estrogen suppression). Most widely prescribed AI in oncology. Research: ER+ breast cancer, T:E2 ratio, reversible vs irreversible AI pharmacology, male hypogonadism. CAS 120511-73-1.
Research Applications
Reversible CYP19A1 Inhibition
Competitive Type II AI — ~97% estrogen suppression, washout studies
Breast Cancer Research
Standard-of-care AI reference — ER+ breast cancer models
T:E2 Ratio Manipulation
Testosterone/estradiol titration — male androgen research
AI Class Comparison
Anastrozole (reversible) vs exemestane (irreversible)
Male Hypogonadism
Aromatase excess — estrogen-driven gonadotropin suppression
Quick Specs
| Form | Tablet — 1mg per tablet, 100-tablet bottle |
| CAS Number | 120511-73-1 |
| Molecular Formula | C₁₇H₁₉N₅ |
| Molecular Weight | 293.4 g/mol |
| Compound Type | SERM / Aromatase Inhibitor |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months unopened |
